The associations between attenuated psychosis symptoms and functioning in Black and White youth at clinical high-risk for psychosis

被引:12
|
作者
Rouhakhtar, Pamela Rakhshan [1 ,2 ]
Roemer, Caroline [1 ]
Reeves, Gloria [2 ]
Schiffman, Jason [3 ]
机构
[1] Univ Maryland Baltimore Cty, Dept Psychol, 1000 Hilltop Circle, Baltimore, MD 21250 USA
[2] Univ Maryland, Div Child & Adolescent Psychiat, Sch Med, 701 W Pratt St, Baltimore, MD 21201 USA
[3] Univ Calif Irvine, Dept Psychol Sci, 4201 Social & Behav Sci Gateway, Irvine, CA 92697 USA
关键词
Psychosis; Clinical high-risk; Race; Functioning; Positive symptoms; AFRICAN-AMERICAN; SOCIOECONOMIC-STATUS; MENTAL-HEALTH; RACE; DIAGNOSIS; SCHIZOPHRENIA; NEIGHBORHOOD; INDIVIDUALS; PEOPLE; DISCRIMINATION;
D O I
10.1016/j.schres.2021.11.032
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Extensive research has demonstrated racial disparities, particularly among Black individuals, in both presenta-tion and course of psychosis spectrum disorders. Few studies, however, have examined racial differences in the clinical high-risk (CHR) phase of illness. It is unclear if functional deficits seen in association with CHR symptoms generalize to marginalized racial groups, or whether race may play a role in the link between symptoms and functioning. In a sample of youth at CHR (N = 46), the present study examined the effect of race (Black and White represented in this sample) on the relation between CHR symptoms and social/role functioning. Race had a moderating effect on the relation between CHR symptoms and social functioning for total positive symptom score (p < .04, f2 = 0.10). Although positive symptoms were associated with worse social functioning for White participants, no association was found for Black participants. Follow up analyses indicated suspiciousness was a statistically significant predictor of social functioning for White participants but was unrelated to functioning for Black participants. Results may be indicative of phenomenon experienced by individuals within racial minority groups (e.g., "healthy suspiciousness") or potential measurement validity concerns. Findings further the un-derstanding of racial differences in the CHR phase of illness among White and Black youth and highlight limi-tations of the existing CHR literature and assessment tools for diverse youth.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 50 条
  • [21] Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis
    Yang, Lawrence H.
    Link, Bruce G.
    Ben-David, Shelly
    Gill, Kelly E.
    Girgis, Ragy R.
    Brucato, Gary
    Wonpat-Borja, Ahtoy J.
    Corcoran, Cheryl M.
    SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) : 9 - 15
  • [22] The content of attenuated psychotic symptoms in those at clinical high risk for psychosis
    Marshall, Catherine
    Denny, Erin
    Cadenhead, Kristin S.
    Cannon, Tyrone D.
    Cornblatt, Barbara A.
    McGlashan, Thomas H.
    Perkins, Diana O.
    Seidman, Larry J.
    Tsuang, Ming T.
    Woods, Scott W.
    Walker, Elaine
    Addington, Jean
    PSYCHIATRY RESEARCH, 2014, 219 (03) : 506 - 512
  • [23] The relationship between negative symptoms and cognitive functioning in patients at clinical high risk for psychosis
    Leanza, Letizia
    Egloff, Laura
    Studerus, Erich
    Andreou, Christina
    Heitz, Ulrike
    Ittig, Sarah
    Beck, Katharina
    Uttinger, Martina
    Riecher-Roessler, Anita
    PSYCHIATRY RESEARCH, 2018, 268 : 21 - 27
  • [24] Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis
    Formica, M. J. C.
    Fuller-Tyszkiewicz, M.
    Reininghaus, U.
    Kempton, M.
    Delespaul, P.
    de Haan, L.
    Nelson, B.
    Mikocka-Walus, A.
    Olive, L.
    Ruhrmann, S.
    Rutten, B.
    Riecher-Roessler, A.
    Sachs, G.
    Valmaggia, L.
    van der Gaag, M.
    McGuire, P.
    van Os, J.
    Hartmann, J. A.
    PSYCHOLOGICAL MEDICINE, 2024, 54 (09) : 2254 - 2263
  • [25] The Clinical High-Risk State: Beyond the Prevention of Psychosis
    Morin, Jean-Francois
    Daneault, Jean-Gabriel
    Krebs, Marie-Odile
    Shah, Jai
    Solida-Tozzi, Alessandra
    SANTE MENTALE AU QUEBEC, 2021, 46 (02): : 85 - 112
  • [26] Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study
    Devoe, D. J.
    Lu, L.
    Cannon, T. D.
    Cadenhead, K. S.
    Cornblatt, B. A.
    McGlashan, T. H.
    Perkins, D. O.
    Seidman, L. J.
    Tsuang, M. T.
    Woods, S. W.
    Walker, E. F.
    Mathalon, D. H.
    Bearden, C. E.
    Addington, J.
    SCHIZOPHRENIA RESEARCH, 2021, 227 : 28 - 37
  • [27] Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis
    Catalan, Ana
    Tognin, Stefania
    Kempton, Matthew J.
    Stahl, Daniel
    Salazar de Pablo, Gonzalo
    Nelson, Barnaby
    Pantelis, Christos
    Riecher-Rossler, Anita
    Bressan, Rodrigo
    Barrantes-Vidal, Neus
    Krebs, Marie-Odile
    Nordentoft, Merete
    Ruhrmann, Stephan
    Sachs, Gabriele
    Rutten, Bart P. F.
    van Os, Jim
    de Haan, Lieuwe
    van der Gaag, Mark
    Valmaggia, Lucia R.
    McGuire, Philip
    PSYCHOLOGICAL MEDICINE, 2022, 52 (08) : 1569 - 1577
  • [28] The development of the Content of Attenuated Positive Symptoms Codebook for those at clinical high risk of psychosis
    Marshall, Catherine
    Falukozi, Erin
    Albertin, Monica
    Zhu, Haifeng
    Addington, Jean
    PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES, 2012, 4 (03): : 191 - 202
  • [29] Early prodromal symptoms can predict future psychosis in familial high-risk youth
    Tandon, Neeraj
    Montrose, Debra
    Shah, Jai
    Rajarethinam, R. P.
    Diwadkar, Vaibhav A.
    Keshavan, Matcheri S.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (01) : 105 - 110
  • [30] Environmental context predicts state fluctuations in negative symptoms in youth at clinical high risk for psychosis
    Luther, Lauren
    Raugh, Ian M.
    Collins, Delaney E.
    Berglund, Alysia
    Knippenberg, Anna R.
    Mittal, Vijay A.
    Walker, Elaine F.
    Strauss, Gregory P.
    PSYCHOLOGICAL MEDICINE, 2023, 53 (16) : 7609 - 7618